ClinicalTrials.Veeva

Menu

High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma

University Health Network, Toronto logo

University Health Network, Toronto

Status

Active, not recruiting

Conditions

Pancreatic Ductal Adenocarcinoma

Treatments

Device: Ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT03820661
18-5982

Details and patient eligibility

About

Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Males and females > 18 y
  2. PDAC diagnosed by typical imaging findings or pathology
  3. Scheduled for surgical resection
  4. Contrast enhanced CT scan performed locally at UHN

Exclusion criteria

  1. Inability or unwillingness to provide informed consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

High Resolution Ultasound
Other group
Description:
Diagnostic high resolution ultrasound pre-operatively and intraoperatively
Treatment:
Device: Ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Stephanie Ramotar; Dorian Anglin Facey

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems